GeneDx Holdings Corp. (WGS) Free cash flow

annual FCF:

-$33.99M+$151.87M(+81.71%)
December 31, 2024

Summary

  • As of today (September 10, 2025), WGS annual free cash flow is -$33.99 million, with the most recent change of +$151.87 million (+81.71%) on December 31, 2024.
  • During the last 3 years, WGS annual FCF has risen by +$177.23 million (+83.91%).
  • WGS annual FCF is now at all-time high.

Performance

1-year change

+81.71%

3-year change

+83.91%

5-year change

+0.58%

15-year change

+0.58%

WGS Free cash flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

35.11%
WGS annual free cash flow is higher than 35.11% of companies in Healthcare sector

Range

All-time high

-$33.99M
WGS annual free cash flow is currently at an all-time high

3-year low

-$333.48M

Earnings dates

Last annual earnings report date

Dec 31, 2024
WGS previous annual earnings announcement was published on Dec 31, 2024

Next annual earnings report date

N/A
WGS next annual earnings announcement has not yet been scheduled

OtherWGScash flow metrics

annual CFO

-$28.50M
WGS annual cash flow from operations is -$28.50 million

annual CFF

$44.16M
WGS annual cash flow from financing activities is $44.16 million

annual CFI

-$30.13M
WGS annual cash flow from investing activities is -$30.13 million

annual CAPEX

$5.49M
WGS annual capital expenditures is $5.49 million

quarterly FCF:

$8.05M+$4.00M(+98.64%)
June 30, 2025

Summary

  • As of today (September 10, 2025), WGS quarterly free cash flow is $8.05 million, with the most recent change of +$4.00 million (+98.64%) on June 30, 2025.
  • Over the past year, WGS quarterly FCF has increased by +$13.91 million (+237.46%).
  • WGS quarterly FCF is now at all-time high.

Performance

3-month change

+98.64%

1-year change

+237.46%

3-year change

+109.16%

5-year change

-

WGS quarterly FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

80.98%
WGS quarterly free cash flow is higher than 80.98% of companies in Healthcare sector

Range

All-time high

$8.05M
WGS quarterly free cash flow is currently at an all-time high

3-year low

-$92.64M

Earnings dates

Last quarterly earnings report date

Jun 30, 2025
WGS previous earnings announcement was published on Jun 30, 2025

Next quarterly earnings report date

Oct 28, 2025
WGS next earnings announcement is scheduled for Oct 28, 2025

OtherWGScash flow metrics

quarterly CFO

$10.42M
WGS quarterly cash flow from operations is $10.42 million

quarterly CFF

$346.00K
WGS quarterly cash flow from financing activities is $346.00 thousand

quarterly CFI

-$36.35M
WGS quarterly cash flow from investing activities is -$36.35 million

quarterly CAPEX

$2.37M
WGS quarterly capital expenditures is $2.37 million

TTM FCF:

$830.00K+$13.91M(+106.35%)
June 30, 2025

Summary

  • As of today (September 10, 2025), WGS TTM free cash flow is $830.00 thousand, with the most recent change of +$13.91 million (+106.35%) on June 30, 2025.
  • Over the past year, WGS TTM FCF has increased by +$97.12 million (+100.86%).
  • WGS TTM FCF is now at all-time high.

Performance

3-month change

+106.35%

1-year change

+100.86%

3-year change

+100.27%

5-year change

-

WGS TTM FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

76.34%
WGS TTM free cash flow is higher than 76.34% of companies in Healthcare sector

Range

All-time high

$830.00K
WGS TTM free cash flow is currently at an all-time high

3-year low

-$333.48M

Earnings dates

Last quarterly earnings report date

Jun 30, 2025
WGS previous earnings announcement was published on Jun 30, 2025

Next quarterly earnings report date

Oct 28, 2025
WGS next earnings announcement is scheduled for Oct 28, 2025

OtherWGScash flow metrics

TTM CFO

$13.02M
WGS TTM cash flow from operations is $13.02 million

TTM CFF

$59.05M
WGS TTM cash flow from financing activities is $59.05 million

TTM CFI

-$54.03M
WGS TTM cash flow from investing activities is -$54.03 million

TTM CAPEX

$12.19M
WGS TTM capital expenditures is $12.19 million

Free cash flow Formula

FCF = Cash From Operations − CAPEX

annual FCF

-$33.99M
WGS annual free cash flow is -$33.99 million

annual CFO

-$28.50M
WGS annual cash flow from operations is -$28.50 million

annual CAPEX

$5.49M
WGS annual capital expenditures is $5.49 million

WGS Free cash flow Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+81.7%+237.5%+100.9%
3 y3 years+83.9%+109.2%+100.3%
5 y5 years+0.6%--

WGS Free cash flow Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+89.8%at high+108.7%at high+100.3%
5 y5-yearat high+89.8%at high+108.7%at high+100.3%
alltimeall timeat high+89.8%at high+108.7%at high+100.3%

WGS Free cash flow History

DateAnnualQuarterlyTTM
Jun 2025
-
$8.05M(+98.6%)
$830.00K(-106.3%)
Mar 2025
-
$4.05M(-165.0%)
-$13.08M(-61.5%)
Dec 2024
-$33.99M(-81.7%)
-$6.23M(+23.6%)
-$33.99M(-43.3%)
Sep 2024
-
-$5.04M(-13.9%)
-$59.99M(-37.7%)
Jun 2024
-
-$5.86M(-65.3%)
-$96.29M(-34.4%)
Mar 2024
-
-$16.86M(-47.7%)
-$146.69M(-21.1%)
Dec 2023
-$185.86M(-44.3%)
-$32.23M(-22.0%)
-$185.86M(-15.9%)
Sep 2023
-
-$41.34M(-26.5%)
-$221.12M(-18.8%)
Jun 2023
-
-$56.26M(+0.4%)
-$272.42M(-10.4%)
Mar 2023
-
-$56.02M(-17.0%)
-$304.09M(-8.8%)
DateAnnualQuarterlyTTM
Dec 2022
-$333.48M(+57.9%)
-$67.49M(-27.1%)
-$333.48M(+2.2%)
Sep 2022
-
-$92.64M(+5.3%)
-$326.20M(+5.9%)
Jun 2022
-
-$87.94M(+3.0%)
-$308.12M(+23.3%)
Mar 2022
-
-$85.41M(+41.8%)
-$249.96M(+18.0%)
Dec 2021
-$211.22M(+68.8%)
-
-
Dec 2021
-
-$60.22M(-19.2%)
-$211.76M(+16.8%)
Sep 2021
-
-$74.56M(+150.3%)
-$181.37M(+69.8%)
Jun 2021
-
-$29.78M(-36.9%)
-$106.82M(+38.7%)
Mar 2021
-
-$47.20M(+58.2%)
-$77.03M(+158.2%)
Dec 2020
-$125.10M(+266.0%)
-$29.83M
-$29.83M
Dec 2019
-$34.18M
-
-

FAQ

  • What is GeneDx Holdings Corp. annual free cash flow?
  • What is the all time high annual FCF for GeneDx Holdings Corp.?
  • What is GeneDx Holdings Corp. annual FCF year-on-year change?
  • What is GeneDx Holdings Corp. quarterly free cash flow?
  • What is the all time high quarterly FCF for GeneDx Holdings Corp.?
  • What is GeneDx Holdings Corp. quarterly FCF year-on-year change?
  • What is GeneDx Holdings Corp. TTM free cash flow?
  • What is the all time high TTM FCF for GeneDx Holdings Corp.?
  • What is GeneDx Holdings Corp. TTM FCF year-on-year change?

What is GeneDx Holdings Corp. annual free cash flow?

The current annual FCF of WGS is -$33.99M

What is the all time high annual FCF for GeneDx Holdings Corp.?

GeneDx Holdings Corp. all-time high annual free cash flow is -$33.99M

What is GeneDx Holdings Corp. annual FCF year-on-year change?

Over the past year, WGS annual free cash flow has changed by +$151.87M (+81.71%)

What is GeneDx Holdings Corp. quarterly free cash flow?

The current quarterly FCF of WGS is $8.05M

What is the all time high quarterly FCF for GeneDx Holdings Corp.?

GeneDx Holdings Corp. all-time high quarterly free cash flow is $8.05M

What is GeneDx Holdings Corp. quarterly FCF year-on-year change?

Over the past year, WGS quarterly free cash flow has changed by +$13.91M (+237.46%)

What is GeneDx Holdings Corp. TTM free cash flow?

The current TTM FCF of WGS is $830.00K

What is the all time high TTM FCF for GeneDx Holdings Corp.?

GeneDx Holdings Corp. all-time high TTM free cash flow is $830.00K

What is GeneDx Holdings Corp. TTM FCF year-on-year change?

Over the past year, WGS TTM free cash flow has changed by +$97.12M (+100.86%)
On this page